Podcast Episodes
Back to Search[Rebroadcast] The power of natural killer cells
While our podcast takes a brief break, Labiotech invites you to enjoy some of our favorite episodes. We will return with a brand-new episode on Janua…
1 year, 9 months ago
Looking at 2025 biotech trends with SoftBank Vision Fund
Our guest on the podcast this week is John Cassidy, director of life sciences and healthtech investments at SoftBank Vision Fund.
Softbank Vision Fund…
1 year, 9 months ago
Finding new treatments for peanut allergy
There is a constant risk of severe, potentially life-threatening allergic reactions for individuals with peanut allergies, which leads to significant…
1 year, 10 months ago
Cracking the code of biotech valuations
ambiom is a life science commercial-advisory business development company based in the Slovakian capital of Bratislava.
The company helps its corporat…
1 year, 10 months ago
Can biotech beat mosquito-borne diseases?
Biological control company Oxitec recently launched Sparks, a new platform designed to rapidly scale Wolbachia replacement technology to take on deng…
1 year, 10 months ago
Could antigen modulation address autoimmune diseases?
Immunology is a key area in biotech and biopharma, both in terms of R&D and sales.
However, according to UK-headquartered Greywolf Therapeutics, the i…
1 year, 10 months ago
Beyond profits: The Bill & Melinda Gates MRI's mission to combat neglected diseases
The Bill & Melinda Gates Medical Research Institute (Gates MRI) is a non-profit medical research organization dedicated to the development and effect…
1 year, 11 months ago
How to succeed as a woman in biotech
This week, we are taking a look at an important subject, and that is women working as CEOs, or other senior roles, in the biotech space.
Kate Yen is …
1 year, 11 months ago
The immunometabolism landscape
Sitryx Therapeutics is a private UK biopharma company founded in 2018. It is a leader in the field of immunometabolism, an area of immunology that lo…
1 year, 11 months ago
Biotech beyond earth: The future of medicine in space
LinkGevity, founded by two sisters, is developing anti-necrotic technologies, especially for application in kidney disease.
Carina Kern is the CEO of …
1 year, 11 months ago